Ratio Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://ratiotx.com
Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer
Early Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2023-03-17
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Ratio Therapeutics, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT05773703
- Locations
- 🇺🇸
Advanced Molecular Imaging & Therapy, Glen Burnie, Maryland, United States
🇺🇸XCancer Omaha/Urology Cancer Center, Omaha, Nebraska, United States
🇺🇸University of Tennessee Medical Center, Knoxville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath